Search Publications
37 results found
-
ACM closes investigation into AstraZeneca
Decision on possible abuse of a dominant position by AstraZeneca about pricing strategy for Nexium. Dominance has not been established. No sanction has been imposed.
Publication News -
No abuse of a dominant position by AstraZeneca
Decision on possible abuse of a dominant position by AstraZeneca about pricing strategy for Nexium. Dominance has not been established. No sanction has been imposed.
Publication Decisions -
KPN fined for putting large business customers at a disadvantage
The Netherlands Authority for Consumers and Markets (ACM) has imposed a fine of EUR 900,000 on Dutch telecom provider KPN
Publication News -
Cooperation agreement rail freight corridor 1
Cooperation agreement between regulatory bodies situated in the countries on rail freight corridor 1.
Publication Regulations -
Cooperation agreement rail freight corridor 2
Cooperation agreement between regulatory bodies
situated in the countries on rail freight corridor 2.Publication Regulations -
The Art of Supervision
This Liber Amicorum has been created on the occasion of Pieter Kalbfleisch’s retirement in June 2011 as chairman of the Board of the Netherlands Competition Authority (NMa).
Publication Visions & opinions -
Buma/Stemra promises ACM to offer more options in music copyright management
Dutch copyright collecting society Buma/Stemra will offer composers and songwriters more options in the management of their music copyrights.
Publication News -
ACM confirms dawn raids at Dutch Railways NS and its subsidiaries QBuzz/Abellio
Last week ACM conducted dawn raids at Dutch Railways NS and its subsidiaries QBuzz/Abellio.
Publication News -
ACM has appointed five new Non-Governmental Advisors
ACM has appointed five new Non-Governmental Advisors (NGAs). One of their duties is to help promote international cooperation in the world of competition.
Publication News -
ACM extends its investigation into orphan drug CDCA-Leadiant
ACM extends its investigation into the orphan drug CDCA manufactured by Leadiant. The investigation focuses on the pricing of the drug, and on possible abuse of a dominant position.
Publication News